Industry Verticals »

All Categories

Insights »

About TMR »

Cardiac Biomarker Diagnostic Kits Market

Cardiac Biomarker Diagnostic Kits Market (Product - Troponin Test Kits, CK-MB Test Kits, Myoglobin Test Kits, BNP Test Kit, C-reactive Protein (hsCRP), Other Biomarkers; Disease Indication - Angina Pectoris, Myocardial Infraction (MI), Cardiac Heart Failure; Testing - Laboratory Testing, Point of Care Testing; End user - Hospitals, Clinics, Diagnostics Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the Global Cardiac Biomarker Diagnostic Kits market for the historical period 2017–2018 and forecast period 2019–2027, rising prevalence of cardiovascular disorders across the globe and advancements in novel technologies are projected to drive the global cardiac biomarker diagnostic kits market during the forecast period
  • According to the report, the global cardiac biomarker diagnostic kits market was valued at US$ 2.2 Bn in 2018 and is anticipated to grow at a CAGR of 5.2% from 2019 to 2027

Rising prevalence of cardiovascular diseases across the globe : Key Driver

  • Growing prevalence of cardiovascular disorders across the globe is a key factor driving the global cardiac biomarker diagnostic kits market.
  • For instance, as per World Health Organization (WHO), every year around 17.9 million people die due to cardiovascular diseases globally which constitutes an estimated 31% of all deaths worldwide.
  • Advancements and technological innovations prompt patients to opt for easy-to-use and portable medical devices, which is also fuelling the growth of global cardiac biomarker diagnostic kits market
  • Moreover, rising government funding for cardiovascular disease treatment, early detection to track the heart condition, and integration of cardiology & IT are also some of the major factors responsible for the growth of global cardiac biomarker diagnostic kits market

Lack of trained staff and appropriate health care infrastructure in developing economies hamper the market growth

  • A cardiac biomarker involves various technical skills, which require appropriate training to handle the device. Sometimes, hospitals or people from developing countries lack awareness about the biomarker and its handling. It creates a barrier between the manufacturing of the device and usage, thereby restraining the market
  • Also Lack of awareness in developing countries and Negative impact of economic constraint in certain regions & pricing pressure can restrain the global market  growth

Global Cardiac Biomarker Diagnostic Kits Market: North America dominated the global market

  • On the basis of region, the cardiac biomarker diagnostic kits market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
  • North America region is accounted for major market share in the global market owing to higher patient population for cardiac diseases, expansion of high-sensitive cardiac biomarkers, rise in acceptance of point-of-care instruments by hospitals and clinics, advancements in technology, and development of high sensitivity POC testing in the region
  • However, Asia-Pacific region is considered as the most lucrative market during the forecast period from 2019 to 2027. The growth is mainly attributed to developing health care infrastructure, large patient population, increase in funding and investment toward the development of cardiac analyzers, and surge in focus of both international and domestic players in the region

Global Cardiac Biomarker Diagnostic Kits Market: Competitive Landscape

  • This report profiles major players in the global cardiac biomarker diagnostic kits market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global cardiac biomarker diagnostic kits market is highly consolidated, with a few global players accounting for a major share in market.
  • Leading players operating in the global Cardiac biomarker diagnostic kits market are
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Siemens Healthineers
    • bioMérieux SA
    • Ortho Clinical Diagnostics
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • among others

Global Cardiac Biomarker Diagnostic Kits Market: Key Developments

Key players in the global cardiac biomarker diagnostic kits market are engaged in regulatory approvals, new product development, technological advancements, merger, acquisitions & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global cardiac biomarker diagnostic kits market. A few expansion strategies adopted by players operating in the global Cardiac biomarker diagnostic kits market are:

  • In April 2019, US FDA has approved Ortho Clinical Diagnostics VITROS XT MicroSlides which features new, multi-test technology that allows labs to run two tests simultaneously on one MicroSlide
  • In September 2018, Abbott receives CE Mark for first troponin test to help predict the chance of heart attack in apparently healthy adults potentially months to years in advance.

 The report on the global cardiac biomarker diagnostic kits market discussed individual strategies, followed by company profiles of manufacturers of cardiac biomarker diagnostic kits. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global cardiac biomarker diagnostic kits market

Global Cardiac biomarker diagnostic kits market - Segmentation 

Product
  • Troponin Test Kits
  • CK-MB Test Kits
  • Myoglobin Test Kits
  • BNP Test Kits
  • C-reactive Protein (hsCRP)
  • Other Biomarkers

Application
  • Angina Pectoris
  • Myocardial Infarction (MI)
  • Cardiac Heart Failure
  • Others

Testing
  • Laboratory Testing
  • Point-of-care Testing

End-user
  • Hospitals
  • Clinics
  • Diagnostic Laboratory

Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of cardiac biomarker diagnostic kits market?

Cardiac biomarker diagnostic kits market to reach valuation of around US$ 3.5 Bn by 2027

What is the anticipated CAGR of the cardiac biomarker diagnostic kits market in the forecast period?

Cardiac biomarker diagnostic kits market is anticipated to grow at a CAGR of 5.2% from 2019 to 2027

What are the key driving factors for the growth of the cardiac biomarker diagnostic kits market?

Cardiac biomarker diagnostic kits market is driven by rising prevalence of cardiovascular disorders across the globe

Which region is expected to project the highest market share in the global cardiac biomarker diagnostic kits market?

North America accounted for a major share of the global cardiac biomarker diagnostic kits market owing to higher patient population for cardiac diseases

Who are the key players in the cardiac biomarker diagnostic kits market?

Key players in the global Cardiac biomarker diagnostic kits market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthineers, bioMérieux SA, Ortho Clinical Diagnostics

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Cardiac Biomarker Diagnostic Kits Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Products Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

                4.3.1.1. Rising prevalence of cardiovascular disorders

                4.3.1.2. Advancements in novel technologies

                4.3.1.3. Integration of cardiology & IT

                4.3.1.4. Early detection to track the heart condition

                4.3.1.5. Government funding for cardiovascular disease treatment

            4.3.2. Restraints

                4.3.2.1. Negative impact of economic constraint in certain regions & pricing pressure

                4.3.2.2. Lack of trained staff and appropriate health care infrastructure in developing economies

                4.3.2.3. Lack of awareness in developing countries

                4.3.2.4. Regulatory challenges

            4.3.3. Trends

        4.4. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

        4.5. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Regulatory Scenario by Region/Globally

        5.2. Key Mergers & Acquisitions

        5.3. Reimbursement Scenario 

        5.4. Cardiac Diseases Prevalence Rate Globally with Key Countries

        5.5. Top 3 players operating in the market space

    6. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Products 

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Products, 2017–2027

            6.3.1. Troponin Test Kits 

            6.3.2. CK-MB Test Kits

            6.3.3. Myoglobin Test Kits

            6.3.4. BNP Test Kit

            6.3.5. C-reactive Protein (hsCRP)

            6.3.6. Others

        6.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Products 

    7. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Testing 

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2017–2027

            7.3.1. Laboratory Testing

            7.3.2. Pont-of-care Testing

        7.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Testing 

    8. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Application 

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Application, 2017–2027

            8.3.1. Angina Pectoris

            8.3.2. Myocardial Infraction

            8.3.3. Cardiac Heart Failure

            8.3.4. Other

        8.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application 

    9. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by End-user 

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2017–2027

            9.3.1. Hospitals

            9.3.2. Clinics

            9.3.3. Diagnostic Laboratory

            9.3.4. Others

        9.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by End-user 

    10. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Region

            10.2.1. North America 

            10.2.2. Europe 

            10.2.3. Asia Pacific 

            10.2.4. Latin America 

            10.2.5. Middle East & Africa 

        10.3. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Region

    11. North America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

         11.1. Introduction

            11.1.1. Key Findings

        11.2. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Products, 2017–2027

            11.2.1. Troponin Test Kits 

            11.2.2. CK-MB Test Kits

            11.2.3. Myoglobin Test Kits

            11.2.4. BNP Test Kit

            11.2.5. C-reactive Protein (hsCRP)

            11.2.6. Others

        11.3. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2017–2027

            11.3.1. Laboratory Testing

            11.3.2. Pont-of-care Testing

        11.4. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Application, 2017–2027

            11.4.1. Angina Pectoris

            11.4.2. Myocardial Infraction

            11.4.3. Cardiac Heart Failure

            11.4.4. Other

        11.5. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2017–2027

            11.5.1. Hospitals

            11.5.2. Clinics

            11.5.3. Diagnostic Laboratory

            11.5.4. Others

        11.6. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country, 2017–2027

            11.6.1. U.S.

            11.6.2. Canada

        11.7. North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 

            11.7.1. By Products 

            11.7.2. By Testing 

            11.7.3. By Application 

            11.7.4. By End-user 

            11.7.5. By Country

    12. Europe Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Products, 2017–2027

            12.2.1. Troponin Test Kits 

            12.2.2. CK-MB Test Kits

            12.2.3. Myoglobin Test Kits

            12.2.4. BNP Test Kit

            12.2.5. C-reactive Protein (hsCRP)

            12.2.6. Others

        12.3. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2017–2027

            12.3.1. Laboratory Testing

            12.3.2. Pont-of-care Testing

        12.4. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Application, 2017–2027

            12.4.1. Angina Pectoris

            12.4.2. Myocardial Infraction

            12.4.3. Cardiac Heart Failure

            12.4.4. Other

        12.5. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2017–2027

            12.5.1. Hospitals

            12.5.2. Clinics

            12.5.3. Diagnostic Laboratory

            12.5.4. Others

        12.6. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2017–2027

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Spain

            12.6.5. Italy

            12.6.6. Rest of Europe

        12.7. Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 

            12.7.1. By Products 

            12.7.2. By Testing 

            12.7.3. by Application 

            12.7.4. by End-user 

            12.7.5. by Country/Sub-region

    13. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Products, 2017–2027

            13.2.1. Troponin Test Kits 

            13.2.2. CK-MB Test Kits

            13.2.3. Myoglobin Test Kits

            13.2.4. BNP Test Kit

            13.2.5. C-reactive Protein (hsCRP)

            13.2.6. Others

        13.3. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2017–2027

            13.3.1. Laboratory Testing

            13.3.2. Pont-of-care Testing

        13.4. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Application, 2017–2027

            13.4.1. Angina Pectoris

            13.4.2. Myocardial Infraction

            13.4.3. Cardiac Heart Failure

            13.4.4. Other

        13.5. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2017–2027

            13.5.1. Hospitals

            13.5.2. Clinics

            13.5.3. Diagnostic Laboratory

            13.5.4. Others

        13.6. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2017–2027

            13.6.1. China

            13.6.2. Japan

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 

            13.7.1. By Products 

            13.7.2. By Testing 

            13.7.3. By Application 

            13.7.4. By End-user 

            13.7.5. By Country/Sub-region

    14. Latin America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Products, 2017–2027

            14.2.1. Troponin Test Kits 

            14.2.2. CK-MB Test Kits

            14.2.3. Myoglobin Test Kits

            14.2.4. BNP Test Kit

            14.2.5. C-reactive Protein (hsCRP)

            14.2.6. Others

        14.3. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2017–2027

            14.3.1. Laboratory Testing

            14.3.2. Pont-of-care Testing

        14.4. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Application, 2017–2027

            14.4.1. Angina Pectoris

            14.4.2. Myocardial Infraction

            14.4.3. Cardiac Heart Failure

            14.4.4. Other

        14.5. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2017–2027

            14.5.1. Hospitals

            14.5.2. Clinics

            14.5.3. Diagnostic Laboratory

            14.5.4. Others

        14.6. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2017–2027

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 

            14.7.1. By Products 

            14.7.2. By Testing 

            14.7.3. By Application 

            14.7.4. By End-user 

            14.7.5. By Country/Sub-region

    15. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Products, 2017–2027

            15.2.1. Troponin Test Kits 

            15.2.2. CK-MB Test Kits

            15.2.3. Myoglobin Test Kits

            15.2.4. BNP Test Kit

            15.2.5. C-reactive Protein (hsCRP)

            15.2.6. Others

        15.3. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2017–2027

            15.3.1. Laboratory Testing

            15.3.2. Pont-of-care Testing

        15.4. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Application, 2017–2027

            15.4.1. Angina Pectoris

            15.4.2. Myocardial Infraction

            15.4.3. Cardiac Heart Failure

            15.4.4. Other

        15.5. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2017–2027

            15.5.1. Hospitals

            15.5.2. Clinics

            15.5.3. Diagnostic Laboratory

            15.5.4. Others

        15.6. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2017–2027

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of Middle East & Africa

        15.7. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 

            15.7.1. By Products 

            15.7.2. By Testing 

            15.7.3. By Application 

            15.7.4. By End-user 

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player – Competition Matrix (by Tier and Size of companies)

        16.2. Market Share Analysis by Company (2017)

        16.3. Competitive Business Strategies

        16.4. Company Profiles

            16.4.1. Abbott Laboratories

                16.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.1.2. Company Financials

                16.4.1.3. Growth Strategies

                16.4.1.4. SWOT Analysis

            16.4.2. Hoffmann-La Roche AG

                16.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.2.2. Company Financials

                16.4.2.3. Growth Strategies

                16.4.2.4. SWOT Analysis

            16.4.3. Bio-Rad Laboratories

                16.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.3.2. Company Financials

                16.4.3.3. Growth Strategies

                16.4.3.4. SWOT Analysis

            16.4.4. Danaher Corporation

                16.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.4.2. Company Financials

                16.4.4.3. Growth Strategies

                16.4.4.4. SWOT Analysis

            16.4.5. Seimens Healthineers

                16.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.5.2. Company Financials

                16.4.5.3. Growth Strategies

                16.4.5.4. SWOT Analysis

            16.4.6. Thermofisher Scientific

                16.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.6.2. Company Financials

                16.4.6.3. Growth Strategies

                16.4.6.4. SWOT Analysis

            16.4.7. bioMérieux SA

                16.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.7.2. Company Financials

                16.4.7.3. Growth Strategies

                16.4.7.4. SWOT Analysis

            16.4.8. Ortho Clinical Diagnostics 

                16.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.8.2. Company Financials

                16.4.8.3. Growth Strategies

                16.4.8.4. SWOT Analysis

    List of Table

    Table 01: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 02: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 03: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2017–2027

    Table 04: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 05: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 06: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 07: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 08: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2017–2027

    Table 09: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 10: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 11: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 12: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 13: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2017–2027

    Table 14: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 15: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 16: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 17: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 18: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2017–2027

    Table 19: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 20: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 21: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 22: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 23: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2017–2027

    Table 24: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 25: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 26: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 27: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 28: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2017–2027

    Table 29: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 30: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    List of Figure

    Figure 01: Global Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2018 and 2027

    Figure 02: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2019–2027

    Figure 03: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Troponin Test Kits, 2017–2027

    Figure 04: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CK-MB Test Kits, 2017–2027

    Figure 05: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Myoglobin Test Kits, 2017–2027

    Figure 06: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by BNP Test Kit, 2017–2027

    Figure 07: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by C-reactive Protein (hsCRP), 2017–2027

    Figure 08: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Biomarkers, 2017–2027

    Figure 09: Global Cardiac Biomarker Diagnostic Kits Market Value Share, by Application, 2018 and 2027

    Figure 10: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application, 2019–2027

    Figure 11: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Angina pectoris, 2017–2027

    Figure 12: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Myocardial Infraction (MI), 2017–2027

    Figure 13: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cardiac Heart Failure, 2017–2027

    Figure 14: Global Cardiac Biomarker Diagnostic Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

    Figure 16: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Laboratory Testing, 2017–2027

    Figure 17: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Pont-of-care testing, 2017–2027

    Figure 18: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2019–2027

    Figure 19: Global Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 20: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2017–2027

    Figure 21: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Clinics, 2017–2027

    Figure 22: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Diagnostic Laboratory, 2017–2027

    Figure 23: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2019–2027

    Figure 24: Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Region, 2018 and 2027

    Figure 25: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis by Region, 2019–2027

    Figure 26: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 27: North America Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2018 and 2027

    Figure 28: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2019–2027

    Figure 29: North America Cardiac Biomarker Diagnostic Kits Market Value Share, by Application, 2018 and 2027

    Figure 30: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application, 2019–2027

    Figure 31: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2018 and 2027

    Figure 32: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2019–2027

    Figure 33: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 34: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2019–2027

    Figure 35: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country, 2019–2027

    Figure 36: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country, 2018 and 2027

    Figure 37: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 38: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2018 and 2027

    Figure 39: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2019–2027

    Figure 40: Europe Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2018 and 2027

    Figure 41: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2019–2027

    Figure 42: Europe Cardiac Biomarker Diagnostic Kits Market Value Share, by Application, 2018 and 2027

    Figure 43: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application, 2019–2027

    Figure 44: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 45: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2019–2027

    Figure 46: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 47: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 48: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 49: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2018 and 2027

    Figure 50: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2019–2027

    Figure 51: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share, by Application, 2018 and 2027

    Figure 52: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application, 2019–2027

    Figure 53: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2018 and 2027

    Figure 54: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2019–2027

    Figure 55: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 56: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2019–2027

    Figure 57: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 58: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 59: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 60: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2018 and 2027

    Figure 61: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2019–2027

    Figure 62: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share, by Application, 2018 and 2027

    Figure 63: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application, 2019–2027

    Figure 64: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2018 and 2027

    Figure 65: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2019–2027

    Figure 66: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 67: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2019–2027

    Figure 68: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 69: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 70: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 72: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2019–2027

    Figure 73: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share, by Application, 2018 and 2027

    Figure 74: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Application, 2019–2027

    Figure 75: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2018 and 2027

    Figure 76: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2019–2027

    Figure 77: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 78: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2019–2027

    Figure 79: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 80: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Copyright © Transparency Market Research, Inc. All Rights reserved

Cardiac Biomarker Diagnostic Kits Market

Schedule a Call